Caregen Co Ltd
KOSDAQ:214370
Caregen Co Ltd
Operating Income
Caregen Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Operating Income
₩37.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
Yuhan Corp
KRX:000100
|
Operating Income
₩34.7B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-6%
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Operating Income
-₩37.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Operating Income
₩220.7B
|
CAGR 3-Years
65%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Operating Income
₩8.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Operating Income
₩27.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
47%
|
CAGR 10-Years
16%
|
See Also
What is Caregen Co Ltd's Operating Income?
Operating Income
37.1B
KRW
Based on the financial report for Mar 31, 2024, Caregen Co Ltd's Operating Income amounts to 37.1B KRW.
What is Caregen Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
16%
Over the last year, the Operating Income growth was -2%. The average annual Operating Income growth rates for Caregen Co Ltd have been 5% over the past three years , 16% over the past five years .